Biotrial, a key Phase I CRO to exhibit at two major life science conferences in February 2010.

PRLog (Press Release) - Feb 08, 2010 -
During the 20th AGAH Annual Meeting (http://www.agah.info) from February 21st–23rd, 2010, Biotrial will be exhibiting at Booth #10. This event will review past and present approaches to drug development, and will take a close look at special populations, difficult pharmacokinetic conditions and how to adapt to changing regulatory environments.

From February 23rd–24th, 2010 at the 11th Annual Phase I Clinical Trials (http://www.iir-events.com) Biotrial will be located at Booth #8. Alain Patat, VP Medical Scientific & Quality Affairs at Biotrial, said: “I am looking forward to attending this event, which focuses this year on assessing the significant advances in scientific and technological approaches for obtaining clinical data at earlier stages of drug development. This is a subject of interest for Biotrial who has been involved and committed for many years now to help the life science industry achieve great milestones in early compound development.”
Both of these events provide great platforms to share information and experiences and are an opportunity for Biotrial to meet with our present and future customers. We invite you to visit us at the booth locations indicated, or to contact one of our representatives to schedule an individual meeting: Matthew Koneth (matthew.konneh@biotrial.com) for the Phase I event in London, and Anna Lainé at (anna.laine@biotrial.com) for the AGAH meeting in Germany.